#BEGIN_DRUGCARD DB01973

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H13NO5S

# Chemical_IUPAC_Name:
(2S)-2-amino-3-[(phenylmethane)sulfonyloxy]propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
O-Benzylsulfonyl-Serine

# HET_ID:
SEB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H13NO5S/c11-9(10(12)13)6-16-17(14,15)7-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1

# InChI_Key:
InChIKey=GCZVEKLTOLTWLM-VIFPVBQESA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1973

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
259.279

# Molecular_Weight_Mono:
259.051443221

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Q5P

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
2.30e+00 g/l

# Primary_Accession_No:
DB01973

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754162

# PubChem_Substance_ID:
46506745

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02878

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:40 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_1_General_References:
1738156	Betzel C, Klupsch S, Papendorf G, Hastrup S, Branner S, Wilson KS: Crystal structure of the alkaline proteinase Savinase from Bacillus lentus at 1.4 A resolution. J Mol Biol. 1992 Jan 20;223(2):427-45.
8654411	Remerowski ML, Pepermans HA, Hilbers CW, Van De Ven FJ: Backbone dynamics of the 269-residue protease Savinase determined from 15N-NMR relaxation measurements. Eur J Biochem. 1996 Feb 1;235(3):629-40.
9753430	Kuhn P, Knapp M, Soltis SM, Ganshaw G, Thoene M, Bott R: The 0.78 A structure of a serine protease: Bacillus lentus subtilisin. Biochemistry. 1998 Sep 29;37(39):13446-52.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2349

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
26699

# Drug_Target_1_Name:
Subtilisin Savinase

# Drug_Target_1_Number_of_Residues:
269

# Drug_Target_1_PDB_ID:
1NDQ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00082	Peptidase_S8

# Drug_Target_1_Protein_Sequence:
>Subtilisin Savinase
AQSVPWGISRVQAPAAHNRGLTGSGVKVAVLDTGISTHPDLNIRGGASFVPGEPSTQDGN
GHGTHVAGTIAALNNSIGVLGVAPSAELYAVKVLGASGSGSVSSIAQGLEWAGNNGMHVA
NLSLGSPSPSATLEQAVNSATSRGVLVVAASGNSGAGSISYPARYANAMAVGATDQNNNR
ASFSQYGAGLDIVAPGVNVQSTYPGSTYASLNGTSMATPHVAGAAALVKQKNPSWSNVQI
RNHLKNTATSLGSTNLYGSGLVNAEAATR

# Drug_Target_1_Reaction:
Hydrolysis of proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. Hydrolyses peptide amides

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Subtilisin is an extracellular alkaline serine protease, it catalyzes the hydrolysis of proteins and peptide amides

# Drug_Target_1_SwissProt_ID:
P29600

# Drug_Target_1_SwissProt_Name:
SUBS_BACLE

# Drug_Target_1_Synonyms:
Alkaline protease
EC 3.4.21.62

# Drug_Target_1_Theoretical_pI:
9.63

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
PRSS2

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
7039

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
Not Available

# Drug_Target_2_Name:
Trypsin-2

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P07478

# Drug_Target_2_SwissProt_Name:
TRY2_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
Not Available

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M15201

# Drug_Target_3_GenBank_ID_Protein:
151137

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
clcD

# Drug_Target_3_Gene_Sequence:
>711 bp
ATGTTGACTGAAGGGATATCGATTCAATCGTATGACGGGCATACATTCGGCGCGCTCGTG
GGCTCGCCGGCCAAAGCGCCCGCTCCCGTGATTGTGATCGCTCAAGAAATATTTGGTGTG
AACGCGTTCATGCGAGAAACGGTGTCATGGCTGGTCGACCAGGGGTATGCGGCAGTTTGC
CCTGATCTGTACGCGCGCCAGGCGCCAGGTACAGCACTCGATCCGCAGGATGAGCGCCAG
AGAGAGCAAGCCTACAAGCTCTGGCAGGCCTTCGACATGGAGGCCGGCGTGGGCGATCTG
GAGGCTGCTATCCGCTATGCGCGACACCAACCCTACAGCAACGGCAAGGTGGGATTGGTG
GGGTATTGCCTGGGCGGTGCGCTTGCCTTTCTAGTGGCCGCCAAAGGATACGTGGATCGC
GCCGTAGGCTACTACGGTGTTGGACTGGAGAAGCAGCTCAAGAAGGTCCCGGAAGTCAAG
CATCCGGCGTTGTTTCACATGGGCGGCCAAGACCACTTCGTGCCCGCGCCAAGCCGCCAG
CTGATTACTGAAGGCTTCGGTGCCAATCCATTGCTGCAAGTGCACTGGTACGAAGAGGCC
GGACACTCGTTCGCCAGGACGAGCAGTTCGGGCTATGTGGCGAGTGCCGCGGCGTTGGCC
AACGAACGTAGACTGGATTTCCTGGCGCCCTTGCAGAGCAAGAAGCCATGA

# Drug_Target_3_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_3_General_References:
2380986	Pathak D, Ollis D: Refined structure of dienelactone hydrolase at 1.8 A. J Mol Biol. 1990 Jul 20;214(2):497-525.
3221394	Pathak D, Ngai KL, Ollis D: X-ray crystallographic structure of dienelactone hydrolase at 2.8 A. J Mol Biol. 1988 Nov 20;204(2):435-45.
3804974	Frantz B, Ngai KL, Chatterjee DK, Ornston LN, Chakrabarty AM: Nucleotide sequence and expression of clcD, a plasmid-borne dienelactone hydrolase gene from Pseudomonas sp. strain B13. J Bacteriol. 1987 Feb;169(2):704-9.
9171435	Kasberg T, Seibert V, Schlomann M, Reineke W: Cloning, characterization, and sequence analysis of the clcE gene encoding the maleylacetate reductase of Pseudomonas sp. strain B13. J Bacteriol. 1997 Jun;179(11):3801-3.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2378

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
25555

# Drug_Target_3_Name:
Carboxymethylenebutenolidase

# Drug_Target_3_Number_of_Residues:
236

# Drug_Target_3_PDB_ID:
1DIN

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01738	DLH

# Drug_Target_3_Protein_Sequence:
>Carboxymethylenebutenolidase
MLTEGISIQSYDGHTFGALVGSPAKAPAPVIVIAQEIFGVNAFMRETVSWLVDQGYAAVC
PDLYARQAPGTALDPQDERQREQAYKLWQAFDMEAGVGDLEAAIRYARHQPYSNGKVGLV
GYCLGGALAFLVAAKGYVDRAVGYYGVGLEKQLKKVPEVKHPALFHMGGQDHFVPAPSRQ
LITEGFGANPLLQVHWYEEAGHSFARTSSSGYVASAAALANERRLDFLAPLQSKKP

# Drug_Target_3_Reaction:
4-carboxymethylenebut-2-en-4-olide + H2O = 4-oxohex-2-enedioate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Ring cleavage of cyclic ester dienelactone to produce maleylacetate

# Drug_Target_3_SwissProt_ID:
P0A115

# Drug_Target_3_SwissProt_Name:
CLCD_PSESB

# Drug_Target_3_Synonyms:
DLH
Dienelactone hydrolase
EC 3.1.1.45

# Drug_Target_3_Theoretical_pI:
6.88

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X17403

# Drug_Target_4_GenBank_ID_Protein:
1780857

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
UL80

# Drug_Target_4_Gene_Sequence:
>2127 bp
ATGACGATGGACGAGCAGCAGTCGCAGGCTGTGGCGCCGGTCTACGTGGGCGGCTTTCTC
GCCCGCTACGACCAGTCTCCGGACGAGGCCGAATTGCTGTTGCCGCGGGACGTAGTGGAG
CACTGGTTGCACGCGCAGGGCCAGGGACAGCCTTCGTTGTCGGTCGCGCTCCCGCTCAAC
ATCAACCACGACGACACGGCCGTTGTAGGACACGTTGCGGCGATGCAGAGCGTCCGCGAC
GGTCTTTTTTGCCTGGGCTGCGTCACTTCGCCCAGGTTTCTGGAGATTGTACGCCGCGCT
TCGGAAAAGTCCGAGCTGGTTTCGCGCGGGCCCGTCAGTCCGCTGCAGCCAGACAAGGTG
GTGGAGTTTCTCAGCGGCAGCTACGCCGGCCTCTCGCTCTCCAGCCGGCGCTGCGACGAC
GTGGAGGCCGCGACGTCGCTTTCGGGCTCGGAAACCACGCCGTTCAAACACGTGGCTTTG
TGCAGCGTGGGTCGGCGTCGCGGTACGTTGGCCGTGTACGGGCGCGATCCCGAGTGGGTC
ACACAGCGGTTTCCAGACCTCACGGCGGCCGACCGTGACGGGCTACGTGCACAGTGGCAG
CGCTGCGGCAGCACTGCTGTCGACGCGTCGGGCGATCCCTTTCGCTCAGACAGCTACGGC
CTGTTGGGCAACAGCGTGGACGCGCTCTACATCCGTGAGCGACTGCCCAAGCTGCGCTAC
GACAAGCAACTAGTCGGCGTGACGGAGCGCGAGTCATACGTCAAGGCGAGCGTTTCGCCT
GAGGCGGCGTGCGATATTAAAGCGGCGTCCGCCGAGCGTTCGGGCGACAGCCGCAGTCAG
GCCGCCACGCCGGCGGCTGGGGCGCGCGTTCCCTCTTCGTCCCCGTCGCCTCCAGTCGAA
CCGCCATCTCCTGTACAGCCGCCTGCGCTTCCAGCGTCGCCGTCCGTTCTTCCCGCGGAA
TCACCGCCGTCGCTTTCTCCCTCGGAGCCGGCAGAGGCGGCGTCCATGTCGCACCCTCTG
AGTGCTGCGGTTCCCGCCGCTACGGCTCCTCCAGGTGCTACCGTGGCAGGTGCGTCGCCG
GCTGTGTCGTCTCTAGCGTGGCCTCACGACGGAGTTTATTTACCCAAAGACGCTTTTTTC
TCGCTACTTGGGGCCAGTCGCTCGGCAGTGCCCGTCATGTATCCCGGCGCCGTAGCGGCC
CCTCCTTCTGCTTCGCCAGCACCGCTGCCTTTGCCGTCTTATCCCGCGTCCTACGGCGCC
CCCGTCGTGGGTTACGACCAGTTGGCGGCACGTCACTTTGCGGACTACGTGGATCCCCAT
TATCCCGGGTGGGGTCGGCGTTACGAGCCCGCGCCGTCTTTGCATCCGTCTTATCCCGTG
CCGCCGCCACCATCACCGGCCTATTACCGTCGGCGCGACTCTCCGGGCGGTATGGATGAA
CCACCGTCCGGATGGGAGCGTTACGACGGTGGTCACCGTGGTCAGTCGCAGAAGCAGCAC
CGTCACGGGGGCAGCGGCGGACACAACAAACGCCGTAAGGAAACCGCGGCGGCGTCGTCG
TCGTCCTCGGACGAAGACTTGAGTTTCCCAGGCGAGGCCGAGCACGGCCGGGCACGAAAG
CGTCTAAAAAGTCACGTCAATAGCGACGGTGGAAGTGGCGGGCACGCGGGTTCCAATCAG
CAGCAGCAACAACGTTACGATGAACTGCGGGATGCCATTCACGAGCTGAAACGCGATCTG
TTTGCTGCGCGGCAGAGTTCTACGTTACTTTCGGCGGCTCTTCCCTCTGCGGCCTCTTCC
TCCCCAACTACTACTACCGTGTGTACTCCCACCGGCGAGCTGACGAGTGGCGGAGGAGAA
ACACCCACGGCACTTCTATCCGGAGGTGCCAAGGTAGCTGAGCGCGCTCAGGCCGGCGTG
GTGAACGCCAGTTGCCGCCTCGCTACCGCGTCGGGTTCTGAGGCGGCAACGGCCGGGCCC
TCGACGGCAGGTTCTTCTTCCTGCCCGGCTAGTGTCGTGTTAGCCGCCGCTGCTGCCCAA
GCCGCCGCAGCTTCCCAGAGCCCGCCCAAAGACATGGTAGATCTGAATCGGCGGATTTTT
GTGGCTGCGCTCAATAAGCTCGAGTAA

# Drug_Target_4_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_4_General_References:
12533697	Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ, McGeoch DJ, Hayward GS: The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol. 2003 Jan;84(Pt 1):17-28.
2161319	Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA 3rd, Kouzarides T, Martignetti JA, et al.: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol. 1990;154:125-69.
8805706	Tong L, Qian C, Massariol MJ, Bonneau PR, Cordingley MG, Lagace L: A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature. 1996 Sep 19;383(6597):272-5.
8805707	Qiu X, Culp JS, DiLella AG, Hellmig B, Hoog SS, Janson CA, Smith WW, Abdel-Meguid SS: Unique fold and active site in cytomegalovirus protease. Nature. 1996 Sep 19;383(6597):275-9.
8805708	Shieh HS, Kurumbail RG, Stevens AM, Stegeman RA, Sturman EJ, Pak JY, Wittwer AJ, Palmier MO, Wiegand RC, Holwerda BC, Stallings WC: Three-dimensional structure of human cytomegalovirus protease. Nature. 1996 Sep 19;383(6597):279-82.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2433

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
73852

# Drug_Target_4_Name:
Capsid protein P40

# Drug_Target_4_Number_of_Residues:
708

# Drug_Target_4_PDB_ID:
1LAY

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00716	Peptidase_S21

# Drug_Target_4_Protein_Sequence:
>Capsid protein P40 [Contains: Assemblin
MTMDEQQSQAVAPVYVGGFLARYDQSPDEAELLLPRDVVEHWLHAQGQGQPSLSVALPLN
INHDDTAVVGHVAAMQSVRDGLFCLGCVTSPRFLEIVRRASEKSELVSRGPVSPLQPDKV
VEFLSGSYAGLSLSSRRCDDVEAATSLSGSETTPFKHVALCSVGRRRGTLAVYGRDPEWV
TQRFPDLTAADRDGLRAQWQRCGSTAVDASGDPFRSDSYGLLGNSVDALYIRERLPKLRY
DKQLVGVTERESYVKASVSPEAACDIKAASAERSGDSRSQAATPAAGARVPSSSPSPPVE
PPSPVQPPALPASPSVLPAESPPSLSPSEPAEAASMSHPLSAAVPAATAPPGATVAGASP
AVSSLAWPHDGVYLPKDAFFSLLGASRSAVPVMYPGAVAAPPSASPAPLPLPSYPASYGA
PVVGYDQLAARHFADYVDPHYPGWGRRYEPAPSLHPSYPVPPPPSPAYYRRRDSPGGMDE
PPSGWERYDGGHRGQSQKQHRHGGSGGHNKRRKETAAASSSSSDEDLSFPGEAEHGRARK
RLKSHVNSDGGSGGHAGSNQQQQQRYDELRDAIHELKRDLFAARQSSTLLSAALPSAASS
SPTTTTVCTPTGELTSGGGETPTALLSGGAKVAERAQAGVVNASCRLATASGSEAATAGP
STAGSSSCPASVVLAAAAAQAAAASQSPPKDMVDLNRRIFVAALNKLE

# Drug_Target_4_Reaction:
Cleaves -Ala!Ser- and -Ala!Ala- bonds in the scaffold protein

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
The capsid assembly protein is a component of the capsid core involved in processing and packaging of progeny DNA. Assemblin is a protease which can proteolytically cleave itself and the capsid assembly protein at the C-terminus

# Drug_Target_4_SwissProt_ID:
P16753

# Drug_Target_4_SwissProt_Name:
PPR_HCMVA

# Drug_Target_4_Synonyms:
C- terminal peptide]
Capsid assembly protein
Capsid protein P40 [Contains: Assemblin
EC 3.4.21.97
Gene UL80 protein
Gene UL80.5 protein
Protease

# Drug_Target_4_Theoretical_pI:
6.79

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Secreted protein

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
M65086

# Drug_Target_5_GenBank_ID_Protein:
142457

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
Not Available

# Drug_Target_5_Gene_Sequence:
>1143 bp
ATGAAGAAACCGTTGGGGAAAATTGTCGCAAGCACCGCACTACTCATTTCTGTTGCTTTT
AGTTCATCGATCGCATCGGCTGCTGAAGAAGCAAAAGAAAAATATTTAATTGGCTTTAAT
GAGCAGGAAGCTGTCAGTGAGTTTGTAGAACAAGTAGAGGCAAATGACGAGGTCGCCATT
CTCTCTGAGGAAGAGGAAGTCGAAATTGAATTGCTTCATGAATTTGAAACGATTCCTGTT
TTATCCGTTGAGTTAAGCCCAGAAGATGTGGACGCGCTTGAACTCGATCCAGCGATTTCT
TATATTGAAGAGGATGCAGAAGTAACGACAATGGCGCAATCAGTGCCATGGGGAATTAGC
CGTGTGCAAGCCCCAGCTGCCCATAACCGTGGATTGACAGGTTCTGGTGTAAAAGTTGCT
GTCCTCGATACAGGTATTTCCACTCATCCAGACTTAAATATTCGTGGTGGCGCTAGCTTT
GTACCAGGGGAACCATCCACTCAAGATGGGAATGGGCATGGCACGCATGTGGCTGGGACG
ATTGCTGCTTTAAACAATTCGATTGGCGTTCTTGGCGTAGCACCGAACGCGGAACTATAC
GCTGTTAAAGTATTAGGGGCGAGCGGTTCAGGTTCGGTCAGCTCGATTGCCCAAGGATTG
GAATGGGCAGGGAACAATGGCATGCACGTTGCTAATTTGAGTTTAGGAAGCCCTTCGCCA
AGTGCCACACTTGAGCAAGCTGTTAATAGCGCGACTTCTAGAGGCGTTCTTGTTGTAGCG
GCATCTGGGAATTCAGGTGCAGGCTCAATCAGCTATCCGGCCCGTTATGCGAACGCAATG
GCAGTCGGAGCTACTGACCAAAACAACAACCGCGCCAGCTTTTCACAGTATGGCGCAGGG
CTTGACATTGTCGCACCAGGTGTAAACGTGCAGAGCACATACCCAGGTTCAACGTATGCC
AGCTTAAACGGTACATCGATGGCTACTCCTCATGTTGCAGGTGCAGCAGCCCTTGTTAAA
CAAAAGAACCCATCTTGGTCCAATGTACAAATCCGCAATCATCTAAAGAATACGGCAACG
AGCTTAGGAAGCACGAACTTGTATGGAAGCGGACTTGTCAATGCAGAAGCGGCAACACGC
TAA

# Drug_Target_5_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_5_General_References:
1447775	Sobek H, Hecht HJ, Aehle W, Schomburg D: X-ray structure determination and comparison of two crystal forms of a variant (Asn115Arg) of the alkaline protease from Bacillus alcalophilus refined at 1.85 A resolution. J Mol Biol. 1992 Nov 5;228(1):108-17.
1518788	van der Laan JM, Teplyakov AV, Kelders H, Kalk KH, Misset O, Mulleners LJ, Dijkstra BW: Crystal structure of the high-alkaline serine protease PB92 from Bacillus alcalophilus. Protein Eng. 1992 Jul;5(5):405-11.
2059048	van der Laan JC, Gerritse G, Mulleners LJ, van der Hoek RA, Quax WJ: Cloning, characterization, and multiple chromosomal integration of a Bacillus alkaline protease gene. Appl Environ Microbiol. 1991 Apr;57(4):901-9.
9115441	Martin JR, Mulder FA, Karimi-Nejad Y, van der Zwan J, Mariani M, Schipper D, Boelens R: The solution structure of serine protease PB92 from Bacillus alcalophilus presents a rigid fold with a flexible substrate-binding site. Structure. 1997 Apr 15;5(4):521-32.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2589

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
38853

# Drug_Target_5_Name:
Alkaline protease

# Drug_Target_5_Number_of_Residues:
380

# Drug_Target_5_PDB_ID:
1AH2

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF05922	Subtilisin_N

# Drug_Target_5_Protein_Sequence:
>Alkaline protease precursor
MKKPLGKIVASTALLISVAFSSSIASAAEEAKEKYLIGFNEQEAVSEFVEQVEANDEVAI
LSEEEEVEIELLHEFETIPVLSVELSPEDVDALELDPAISYIEEDAEVTTMAQSVPWGIS
RVQAPAAHNRGLTGSGVKVAVLDTGISTHPDLNIRGGASFVPGEPSTQDGNGHGTHVAGT
IAALNNSIGVLGVAPNAELYAVKVLGASGSGSVSSIAQGLEWAGNNGMHVANLSLGSPSP
SATLEQAVNSATSRGVLVVAASGNSGAGSISYPARYANAMAVGATDQNNNRASFSQYGAG
LDIVAPGVNVQSTYPGSTYASLNGTSMATPHVAGAAALVKQKNPSWSNVQIRNHLKNTAT
SLGSTNLYGSGLVNAEAATR

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
1-27

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
P27693

# Drug_Target_5_SwissProt_Name:
ELYA_BACAO

# Drug_Target_5_Synonyms:
Alkaline protease precursor
EC 3.4.21.-

# Drug_Target_5_Theoretical_pI:
4.39

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB01973
